Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 9 results

Author Title Type [ Year

]

Filters: Author is Alousi, Amin M [Clear All Filters]

2020

Pidala, Joseph, Mehdi Hamadani, Peter Dawson, Michael Martens, Amin M Alousi, Madan Jagasia, Yvonne A Efebera, et al.. 2020. “Randomized Multicenter Trial Of Sirolimus Vs Prednisone As Initial Therapy For Standard-Risk Acute Gvhd: The Bmt Ctn 1501 Trial.”. Blood 135 (2). Blood: 97-107. doi:10.1182/blood.2019003125.

2019

Bolaños-Meade, Javier, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar, Zaid Al-Kadhimi, Amin M Alousi, et al.. 2019. “Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, And Cyclophosphamide; Tacrolimus, Methotrexate, And Bortezomib; Or Tacrolimus, Methotrexate, And Maraviroc) Versus Tacrolimus And Methotrexate For Prevention Of Graft-Versus-Host Disease With”. Lancet Haematol 6 (3). Lancet Haematol: e132-e143. doi:10.1016/S2352-3026(18)30221-7.

2018

Pasquini, Marcelo C, Brent Logan, Richard J Jones, Amin M Alousi, Frederick R Appelbaum, Javier Bolaños-Meade, Mary ED Flowers, et al.. 2018. “Blood And Marrow Transplant Clinical Trials Network Report On The Development Of Novel Endpoints And Selection Of Promising Approaches For Graft-Versus-Host Disease Prevention Trials.”. Biol Blood Marrow Transplant 24 (6). Biol Blood Marrow Transplant: 1274-1280. doi:10.1016/j.bbmt.2018.01.002.

Carpenter, Paul A, Brent R Logan, Stephanie J Lee, Daniel J Weisdorf, Laura Johnston, Luciano J Costa, Carrie L Kitko, et al.. 2018. “A Phase Ii/iii Randomized, Multicenter Trial Of Prednisone/sirolimus Prednisone/ Sirolimus/calcineurin Inhibitor For The Treatment Of Chronic Graft--Host Disease: Bmt Ctn 0801.”. Haematologica 103 (11). Haematologica: 1915-1924. doi:10.3324/haematol.2018.195123.

2014

Bolaños-Meade, Javier, Brent R Logan, Amin M Alousi, Joseph H Antin, Kate Barowski, Shelly L Carter, Steven C Goldstein, et al.. 2014. “Phase 3 Clinical Trial Of Steroids/mycophenolate Mofetil Vs Steroids/placebo As Therapy For Acute Gvhd: Bmt Ctn 0802.”. Blood 124 (22). Blood: 3221-7; quiz 3335. doi:10.1182/blood-2014-06-577023.

2013

Bolaños-Meade, Javier, Juan Wu, Brent R Logan, John E Levine, Vincent T Ho, Amin M Alousi, Daniel J Weisdorf, and Leo Luznik. 2013. “Lymphocyte Phenotype During Therapy For Acute Graft-Versus-Host Disease: A Brief Report From Bmt-Ctn 0302.”. Biol Blood Marrow Transplant 19 (3). Biol Blood Marrow Transplant: 481-5. doi:10.1016/j.bbmt.2012.12.003.

2012

Levine, John E, Brent R Logan, Juan Wu, Amin M Alousi, Javier Bolaños-Meade, James LM Ferrara, Vincent T Ho, Daniel J Weisdorf, and Sophie Paczesny. 2012. “Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood And Marrow Transplant Clinical Trials Network Study.”. Blood 119 (16). Blood: 3854-60. doi:10.1182/blood-2012-01-403063.

2010

Levine, John E, Brent Logan, Juan Wu, Amin M Alousi, Vincent Ho, Javier Bolaños-Meade, and Daniel Weisdorf. 2010. “Graft-Versus-Host Disease Treatment: Predictors Of Survival.”. Biol Blood Marrow Transplant 16 (12). Biol Blood Marrow Transplant: 1693-9. doi:10.1016/j.bbmt.2010.05.019.

2009

Alousi, Amin M, Daniel J Weisdorf, Brent R Logan, Javier Bolaños-Meade, Shelly Carter, Nancy DiFronzo, Marcelo Pasquini, et al.. 2009. “Etanercept, Mycophenolate, Denileukin, Or Pentostatin Plus Corticosteroids For Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial From The Blood And Marrow Transplant Clinical Trials Network.”. Blood 114 (3). Blood: 511-7. doi:10.1182/blood-2009-03-212290.